Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2026-04-20Clinical Trial Update: Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release
Expanded Access program for AMTAGVI is out of specification for commercial release, triggering quality controls and potential safety concern…
-
CLINICAL_TRIALS safety_alert · 2025-10-01Clinical Trial Update: CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma
The clinical trial update reports cardiac toxicity concerns linked to immunotherapy for melanoma and indicates ongoing safety monitoring for…
-
CLINICAL_TRIALS safety_alert · 2017-05-31Clinical Trial Update: Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms
A clinical trial update notes cognitive, affective, and sleep symptoms linked to high-dose interleukin-2. The conditions involved are metast…